Alethia Biotherapeutics Announces Issuance of a Japanese Patent for ... Marketwire (press release) 19, 2013) - Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development of therapeutic monoclonal antibodies, announced today that the Company has been granted its first Japanese patent related to Siglec-15 entitled ... |
